Ivan Van Riet

7.6k citations
130 papers · 5.4k · 1 hit paper · h-index 44

Impact in

  • Hematology top 0.2%
    • Multiple Myeloma Research and Treatments
    • Hematopoietic Stem Cell Transplantation
  • Genetics top 0.5%
    • Mesenchymal stem cell research

Papers in

    • Multiple Myeloma Research and Treatments 62
    • Hematopoietic Stem Cell Transplantation 13
    • Chemokine receptors and signaling 20
    • CAR-T cell therapy research 17

Ivan Van Riet

127 papers receiving 5.3k citations

Ivan Van Riet's Hit Papers

Homing and migration of mesenchymal stromal cells: How to improve the efficacy of cell therapy? 2016 · 377 citations
3770+3+6Years since publication100200300

Peers

Ivan Van Riet
Comparison fields: 5 of 109
  • Hematology 2.4k
  • Genetics 1.2k
  • Immunology and Allergy 501
  • Oncology 2.1k
  • Immunology 1.2k
Replace Robert Möhle with:
Robert Möhle Germany
Ian McNiece United States
Jean-Pierre Lévesque Australia
Virginia C. Broudy United States
Ryan Reca United States
Reinhard Henschler Germany
Katsutoshi Ozaki Japan
M Valtieri Italy
Izhar Hardan Israel
Lewis C. Strauss United States
Ivan Van Riet relative to Robert Möhle Germany Robert Möhle's profile →
Citations per field
00.5×1.5×2.1×
Robert Möhle · 1×
Citations per year

Countries citing papers authored by Ivan Van Riet

Since Specialization
Citations

This map shows the geographic impact of Ivan Van Riet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan Van Riet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan Van Riet more than expected).

Fields of papers citing papers by Ivan Van Riet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivan Van Riet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan Van Riet. The network helps show where Ivan Van Riet may publish in the future.

Co-authors

The 25 scholars most cited alongside Ivan Van Riet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ivan Van Riet Line = papers co-authored together Ivan Van Riet links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 130 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Homing and migration of mesenchymal stromal cells: How to improve the efficacy of cell therapy?
Hit paper breakdown →
2016377
2 1992264
3 1990259
4 2007187
5 2013170
6 2005163
7 1998126
8 1994121
9 1997120
10 2003120
11 2011118
12 2016111
13 2000110
14 200399
15 200299
16 201191
17 199190
18 200690
19 201488
20
The absolute number of circulating CD34+ cells predicts the number of hematopoietic stem cells that can be collected by apheresis.
199687

About Ivan Van Riet

Ivan Van Riet is a scholar working on Hematology, Oncology, Molecular Biology, Immunology and Immunology and Allergy, having authored 130 papers that have together received 5.4k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (62 papers), Immunotherapy and Immune Responses (24 papers), Cell Adhesion Molecules Research (22 papers), Chemokine receptors and signaling (20 papers), CAR-T cell therapy research (17 papers), Glycosylation and Glycoproteins Research (16 papers), Mesenchymal stem cell research (15 papers) and Hematopoietic Stem Cell Transplantation (13 papers). The work is most often cited by research in Hematology (2.4k citations), Genetics (1.2k citations), Immunology and Allergy (501 citations), Oncology (2.1k citations) and Immunology (1.2k citations). Ivan Van Riet has collaborated with scholars based in Belgium, United States and France. Frequent co-authors include Karin Vanderkerken, Ann De Becker, Ben Van Camp, Benjamin Van Camp, Kewal Asosingh, Kris Thielemans, M. De Waele, Isabelle Vande Broek, Carlo Heirman and Eline Menu. Their work appears in journals such as Blood, British Journal of Haematology, Leukemia, European Journal Of Haematology and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact